VEGF receptor signalling ? in control of vascular function
The DOI matches its Crossref record; 140 of the 141 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Vascular endothelial growth-factor receptors (VEGFRs) regulate the cardiovascular system. VEGFR1 is required for the recruitment of haematopoietic precursors and migration of monocytes and macrophages, whereas VEGFR2 and VEGFR3 are essential for the functions of vascular endothelial and lymphendothelial cells, respectively. Recent insights have shed light onto VEGFR signal transduction and the interplay between different VEGFRs and VEGF co-receptors in development, adult physiology and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These proteins collectively contribute to promoting angiogenic activities by influencing endothelial cell proliferation [49,53,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Moreover, EVs’ content also encompasses an array of growth factors such as soluble growth factors like VEGF, TGFB1, IL-8, and HGF.”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Additionally, miRNAs cargos in MSCs EVs such as miR210, miR126, miR132, and miR21 have been identified as contributors to angiogenesis [49,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Flt-1 is one of the main receptors of the vascular endothelial growth factor (VEGF) family widely expressed in the vascular system.33”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [33]
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundTumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,608
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520 · cited 1×
“Hypoxia allows the stabilization of hypoxia-inducible factors (HIFs) that bind to specific promoter elements that are present in the promoter region of VEGF”
BackgroundSoker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,463
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
A mechanosensory complex that mediates the endothelial cell response to fluid shear stress
Tzima, E., Irani-Tehrani, M., Kiosses, W. B., Dejana, E., Schultz, D. A., Engelhardt, B., Cao, G., DeLisser, H., & Schwartz, M. A. (2005) · Nature · doi:10.1038/nature03952 · Cited by 1,711
Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001) · Nature Medicine · doi:10.1038/87904 · Cited by 1,672
Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., & Heldin, C. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47116-5 · Cited by 1,656
Prox1 Function Is Required for the Development of the Murine Lymphatic System
Wigle, J. T., & Oliver, G. (1999) · Cell · doi:10.1016/s0092-8674(00)81511-1 · Cited by 1,579
Karkkainen, M. J., Haiko, P., Sainio, K., Partanen, J., Taipale, J., Petrova, T. V., Jeltsch, M., Jackson, D. G., Talikka, M., Rauvala, H., et al. (2004) · Nature Immunology · doi:10.1038/ni1013 · Cited by 1,421 · cited 1×
“5 in response to a gradient of VEGFC, which is produced by nearby mesenchymal cells”
BackgroundKendall, R. L., & Thomas, K. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10705 · Cited by 1,394 · cited 1×
“Alternative splicing or proteolytic processing of VEGFRs give rise to secreted variants of VEGFR1 (Ref”
BackgroundEndothelial Cell-to-Cell Junctions: Molecular Organization and Role in Vascular Homeostasis
Bazzoni, G., & Dejana, E. (2004) · Physiological Reviews · doi:10.1152/physrev.00035.2003 · Cited by 1,389
Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice
Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K., & Alitalo, K. (1997) · Science · doi:10.1126/science.276.5317.1423 · Cited by 1,283
Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, J. A., Hooper, A., Priller, J., De Klerck, B., et al. (2002) · Nature Medicine · doi:10.1038/nm731 · Cited by 1,068
Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., & Shibuya, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9349 · Cited by 1,062 · cited 1×
“Importantly, deletion of the VEGFR1 tyrosine-kinase domain is compatible with normal vascular development, as demonstrated by the phenotype of Vegfr1 (TK) −/− mic”
BackgroundLessons from phase III clinical trials on anti-VEGF therapy for cancer
Jain, R. K., Duda, D. G., Clark, J. W., & Loeffler, J. S. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0403 · Cited by 1,039
Roberts, W. G., & Palade, G. E. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.6.2369 · Cited by 1,033
Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C.-O., Buerk, D. G., Huang, P. L., & Jain, R. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041359198 · Cited by 1,020
Takahashi, H., & Shibuya, M. (2005) · Clinical Science · doi:10.1042/cs20040370 · Cited by 953 · cited 1×
“In addition, proteins that are structurally related to the VEGFs exist in parapoxviru”
BackgroundVEGF is required for growth and survival in neonatal mice
Gerber, H.-P., Hillan, K. J., Ryan, A. M., Kowalski, J., Keller, G.-A., Rangell, L., Wright, B. D., Radtke, F., Aguet, M., & Ferrara, N. (1999) · Development · doi:10.1242/dev.126.6.1149 · Cited by 915
Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C., & Shima, D. T. (2002) · Genes & Development · doi:10.1101/gad.242002 · Cited by 914
Pathophysiological consequences of VEGF-induced vascular permeability
Weis, S. M., & Cheresh, D. A. (2005) · Nature · doi:10.1038/nature03987 · Cited by 909
Cardiovascular Failure in Mouse Embryos Deficient in VEGF Receptor-3
Dumont, D. J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M., & Alitalo, K. (1998) · Science · doi:10.1126/science.282.5390.946 · Cited by 874
Rousseau, S., Houle, F., Landry, J., & Huot, J. (1997) · Oncogene · doi:10.1038/sj.onc.1201380 · Cited by 845
Makinen, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4762 · Cited by 845
A requirement for neuropilin-1 in embryonic vessel formation
Kawasaki, T., Kitsukawa, T., Bekku, Y., Matsuda, Y., Sanbo, M., Yagi, T., & Fujisawa, H. (1999) · Development · doi:10.1242/dev.126.21.4895 · Cited by 827
Lawson, N. D., Vogel, A. M., & Weinstein, B. M. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00198-3 · Cited by 813
Selective Requirement for Src Kinases during VEGF-Induced Angiogenesis and Vascular Permeability
Eliceiri, B. P., Paul, R., Schwartzberg, P. L., Hood, J. D., Leng, J., & Cheresh, D. A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80221-x · Cited by 813
Differential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor Genes
Gerber, H.-P., Condorelli, F., Park, J., & Ferrara, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23659 · Cited by 794
Mäkinen, T., Jussila, L., Veikkola, T., Karpanen, T., Kettunen, M. I., Pulkkanen, K. J., Kauppinen, R., Jackson, D. G., Kubo, H., Nishikawa, S.-I., et al. (2001) · Nature Medicine · doi:10.1038/84651 · Cited by 777
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
Kamba, T., Tam, B. Y. Y., Hashizume, H., Haskell, A., Sennino, B., Mancuso, M. R., Norberg, S. M., O'Brien, S. M., Davis, R. B., Gowen, L. C., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00133.2005 · Cited by 775 · cited 1×
“Even a short-term, pharmacological block of the interaction between VEGFA and VEGFR2 in adult mice leads to vessel regressio”
BackgroundRole of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
Autiero, M., Waltenberger, J., Communi, D., Kranz, A., Moons, L., Lambrechts, D., Kroll, J., Plaisance, S., De Mol, M., Bono, F., et al. (2003) · Nature Medicine · doi:10.1038/nm884 · Cited by 773
Takahashi, T. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2768 · Cited by 749
Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., & Dvorak, A. M. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_6 · Cited by 743
VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism
Gerber, H.-P., Malik, A. K., Solar, G. P., Sherman, D., Liang, X. H., Meng, G., Hong, K., Marsters, J. C., & Ferrara, N. (2002) · Nature · doi:10.1038/nature00821 · Cited by 706 · cited 1×
“Indeed, it has been shown that survival of haematopoietic stem cells is promoted by VEGF”
BackgroundLee, S., Jilani, S. M., Nikolova, G. V., Carpizo, D., & Iruela-Arispe, M. L. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200409115 · Cited by 703
Carmeliet, P., Ng, Y.-S., Nuyens, D., Theilmeier, G., Brusselmans, K., Cornelissen, I., Ehler, E., Kakkar, V. V., Stalmans, I., Mattot, V., et al. (1999) · Nature Medicine · doi:10.1038/8379 · Cited by 679
Kitsukawa, T., Shimizu, M., Sanbo, M., Hirata, T., Taniguchi, M., Bekku, Y., Yagi, T., & Fujisawa, H. (1997) · Neuron · doi:10.1016/s0896-6273(00)80392-x · Cited by 656
Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema
Karkkainen, M. J., Ferrell, R. E., Lawrence, E. C., Kimak, M. A., Levinson, K. L., McTigue, M. A., Alitalo, K., & Finegold, D. N. (2000) · Nature Genetics · doi:10.1038/75997 · Cited by 650
Hattori, K., Heissig, B., Wu, Y., Dias, S., Tejada, R., Ferris, B., Hicklin, D. J., Zhu, Z., Bohlen, P., Witte, L., et al. (2002) · Nature Medicine · doi:10.1038/nm740 · Cited by 633 · cited 1×
“The important role of VEGFR1 in haematopoietic-cell function is furthermore underscored by the fact that PLGF-stimulated VEGFR1-positive HPCs can rescue haematopoiesis after bone-marrow destructio”
BackgroundAbnormal lymphatic vessel development in neuropilin 2 mutant mice
Yuan, L., Moyon, D., Pardanaud, L., Bréant, C., Karkkainen, M. J., Alitalo, K., & Eichmann, A. (2002) · Development · doi:10.1242/dev.129.20.4797 · Cited by 632
Petrova, T. V., Mäkinen, T., Mäkelä, T. P., Saarela, J., Virtanen, I., Ferrell, R. E., Finegold, D. N., Kerjaschki, D., Ylä‐Herttuala, S., & Alitalo, K. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf470 · Cited by 632
Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2
Soldi, R., Mitola, S., Strasly, M., Defilippi, P., Tarone, G., & Bussolino, F. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.882 · Cited by 626
Takahashi, T., Ueno, H., & Shibuya, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202527 · Cited by 571
Nagy, J. A., Vasile, E., Feng, D., Sundberg, C., Brown, L. F., Detmar, M. J., Lawitts, J. A., Benjamin, L., Tan, X., Manseau, E. J., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021244 · Cited by 559 · cited 1×
“Also, VEGFA has been shown to induce lymphangiogenesis, presumably through VEGFR2, as indicated by the effect of VEGFA-encoding adenovirus delivery into the mouse ea”
BackgroundFujio, Y., & Walsh, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16349 · Cited by 553
VEGF Receptor Signal Transduction
Matsumoto, T., & Claesson-Welsh, L. (2001) · Science's STKE · doi:10.1126/stke.2001.112.re21 · Cited by 502
Abedi, H., & Zachary, I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15442 · Cited by 471 · cited 1×
“Other signalling molecules that have been implicated in VEGF-induced migration through VEGFR2 include the focal-adhesion kinase (FAK) and its substrate paxilli”
BackgroundSeetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S., & Shibuya, M. (1995) · PubMed · Cited by 464
Fong, G.-H., Zhang, L., Bryce, D.-M., & Peng, J. (1999) · Development · doi:10.1242/dev.126.13.3015 · Cited by 459
Maes, C., Carmeliet, P., Moermans, K., Stockmans, I., Smets, N., Collen, D., Bouillon, R., & Carmeliet, G. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00601-3 · Cited by 456
Muller, Y. A., Li, B., Christinger, H. W., Wells, J. A., Cunningham, B. C., & de Vos, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7192 · Cited by 452 · cited 1×
“The crystal structure of VEGFA revealed two monomers that are organized in an anti-parallel fashion to form a dimer, with the receptor-binding sites located at each pole of the dime”
BackgroundVEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant
Woolard, J., Wang, W.-Y., Bevan, H. S., Qiu, Y., Morbidelli, L., Pritchard-Jones, R. O., Cui, T.-G., Sugiono, M., Waine, E., Perrin, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0934 · Cited by 451 · cited 1×
“Another splice variant of VEGFA, known as VEGF165b, has been proposed to negatively regulate VEGFR activit”
BackgroundSkeletal defects in VEGF120/120 mice reveal multiple roles for VEGF in skeletogenesis
Zelzer, E., McLean, W., Ng, Y.-S., Fukai, N., Reginato, A. M., Lovejoy, S., D’Amore, P. A., & Olsen, B. R. (2002) · Development · doi:10.1242/dev.129.8.1893 · Cited by 445
Kroll, J., & Waltenberger, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.51.32521 · Cited by 430 · cited 1×
“Conflicting results exist in the literature with respect to the interaction of VEGFR2 with ShcA or Grb2, which recruit the Ras-activating nucleotide-exchange factor son of sevenless to the recepto”
BackgroundMiquerol, L., Langille, B. L., & Nagy, A. (2000) · Development · doi:10.1242/dev.127.18.3941 · Cited by 429
Neuropilin-2 Is Required In Vivo for Selective Axon Guidance Responses to Secreted Semaphorins
Giger, R. J., Cloutier, J.-F., Sahay, A., Prinjha, R. K., Levengood, D. V., Moore, S. E., Pickering, S., Simmons, D., Rastan, S., Walsh, F. S., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80869-7 · Cited by 426
Regulation of vascular permeability by vascular endothelial growth factors
Bates, D. O., & Harper, S. J. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(03)00011-9 · Cited by 411
Kitsukawa, T., Shimono, A., Kawakami, A., Kondoh, H., & Fujisawa, H. (1995) · Development · doi:10.1242/dev.121.12.4309 · Cited by 410
Saharinen, P., Tammela, T., Karkkainen, M. J., & Alitalo, K. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.05.003 · Cited by 391 · cited 1×
“These heterodimeric receptors might form in vivo both in lymphatic endothelial cells and in certain endothelial cells, such as in fenestrated capillaries , which express both receptor type”
BackgroundHiratsuka, S., Maru, Y., Okada, A., Seiki, M., Noda, T., & Shibuya, M. (2001) · PubMed · Cited by 388
Hart, M. J., Callow, M. G., Souza, B., & Polakis, P. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00663.x · Cited by 384
Takashima, S., Kitakaze, M., Asakura, M., Asanuma, H., Sanada, S., Tashiro, F., Niwa, H., Miyazaki, J.-I., Hirota, S., Kitamura, Y., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022017899 · Cited by 372
Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms
Stalmans, I., Ng, Y.-S., Rohan, R., Fruttiger, M., Bouché, A., Ÿuce, A., Fujisawa, H., Hermans, B., Shani, M., Jansen, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214362 · Cited by 358
Autiero, M., Luttun, A., Tjwa, M., & Carmeliet, P. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00263.x · Cited by 357 · cited 1×
“showed that VEGF and PLGF might induce different phosphorylation-site patterns in VEGFR1 (Ref”
BackgroundBellomo, D., Headrick, J. P., Silins, G. U., Paterson, C. A., Thomas, P. S., Gartside, M., Mould, A., Cahill, M. M., Tonks, I. D., Grimmond, S. M., et al. (2000) · Circulation Research · doi:10.1161/01.res.86.2.e29 · Cited by 333
Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice
Sakurai, Y., Ohgimoto, K., Kataoka, Y., Yoshida, N., & Shibuya, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404984102 · Cited by 330
Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression
Miao, H., Lee, P., Lin, H., Soker, S., & Klagsbrun, M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0250com · Cited by 312
Zeng, H., Dvorak, H. F., & Mukhopadhyay, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103213200 · Cited by 294
VEGF receptor‐2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis
Matsumoto, T., Bohman, S., Dixelius, J., Berge, T., Dimberg, A., Magnusson, P., Wang, L., Wikner, C., Qi, J. H., Wernstedt, C., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600709 · Cited by 292
Self-citationVascular Endothelial Growth Factor D Is Dispensable for Development of the Lymphatic System
Baldwin, M. E., Halford, M. M., Roufail, S., Williams, R. A., Hibbs, M. L., Grail, D., Kubo, H., Stacker, S. A., & Achen, M. G. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2441-2449.2005 · Cited by 289
Dixelius, J., Mäkinen, T., Wirzenius, M., Karkkainen, M. J., Wernstedt, C., Alitalo, K., & Claesson-Welsh, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304499200 · Cited by 284
Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras Activation
Meadows, K. N., Bryant, P., & Pumiglia, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108069200 · Cited by 278 · cited 1×
“However, VEGF stimulates activation of Ras in human umbilical-vein endothelial cells (HUVECs”
BackgroundShu, X., Wu, W., Mosteller, R. D., & Broek, D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7758-7768.2002 · Cited by 278
Heparan Sulfate in trans Potentiates VEGFR-Mediated Angiogenesis
Jakobsson, L., Kreuger, J., Holmborn, K., Lundin, L., Eriksson, I., Kjellén, L., & Claesson-Welsh, L. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.03.009 · Cited by 274
Self-citationMaes, C., Stockmans, I., Moermans, K., Van Looveren, R., Smets, N., Carmeliet, P., Bouillon, R., & Carmeliet, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19383 · Cited by 266
Holmqvist, K., Cross, M. J., Rolny, C., Hägerkvist, R., Rahimi, N., Matsumoto, T., Claesson-Welsh, L., & Welsh, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312729200 · Cited by 265
Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1)
Shibuya, M. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00026-7 · Cited by 260
Fuh, G., Li, B., Crowley, C., Cunningham, B., & Wells, J. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.18.11197 · Cited by 259 · cited 1×
“In addition, biochemical analyses showed that the Ig domain-3 in VEGFR2 is important for the determination of ligand-binding specificit”
BackgroundThe PDGF/VEGF Receptor Controls Blood Cell Survival in Drosophila
Brückner, K., Kockel, L., Duchek, P., Luque, C. M., Rørth, P., & Perrimon, N. (2004) · Developmental Cell · doi:10.1016/j.devcel.2004.06.007 · Cited by 249
Ets1-Related Protein Is a Key Regulator of Vasculogenesis in Zebrafish
Sumanas, S., & Lin, S. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0040010 · Cited by 244
Yamaoka-Tojo, M., Ushio-Fukai, M., Hilenski, L., Dikalov, S. I., Chen, Y. E., Tojo, T., Fukai, T., Fujimoto, M., Patrushev, N. A., Wang, N., et al. (2004) · Circulation Research · doi:10.1161/01.res.0000136522.58649.60 · Cited by 237 · cited 1×
“IQGAP1 co-localizes with phosphorylated VEGFR2 at the leading edge of migrating endothelial cells and IQGAP1 knockdown by siRNA prevents VEGF-induced migratio”
BackgroundRahimi, N., Dayanir, V., & Lashkari, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000528200 · Cited by 236
Lawson, N. D., Mugford, J. W., Diamond, B. A., & Weinstein, B. M. (2003) · Genes & Development · doi:10.1101/gad.1072203 · Cited by 233
Maes, C., Stockmans, I., Moermans, K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419383 · Cited by 233
Analysis of a Zebrafish VEGF Receptor Mutant Reveals Specific Disruption of Angiogenesis
Habeck, H., Odenthal, J., Walderich, B., Maischein, H.-M., & Schulte-Merker, S. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01044-8 · Cited by 229
Lamalice, L., Houle, F., Jourdan, G., & Huot, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207034 · Cited by 224
Regulators of Endocytosis Maintain Localized Receptor Tyrosine Kinase Signaling in Guided Migration
Jékely, G., Sung, H.-H., Luque, C. M., & Rørth, P. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.06.004 · Cited by 224
Lee, P., Goishi, K., Davidson, A. J., Mannix, R., Zon, L., & Klagsbrun, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162366299 · Cited by 215
Ebos, J. M. L., Bocci, G., Man, S., Thorpe, P. E., Hicklin, D. J., Zhou, D., Jia, X., & Kerbel, R. S. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.315.2.6 · Cited by 211
Integrins and angiogenesis: A sticky business
SERINI, G., VALDEMBRI, D., & BUSSOLINO, F. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.10.020 · Cited by 206
Vascular Endothelial Growth Factor-B–Deficient Mice Display an Atrial Conduction Defect
Aase, K., von Euler, G., Li, X., Pontén, A., Thorén, P., Cao, R., Cao, Y., Olofsson, B., Gebre-Medhin, S., Pekny, M., et al. (2001) · Circulation · doi:10.1161/01.cir.104.3.358 · Cited by 197
Kinetic Model for FGF, FGFR, and Proteoglycan Signal Transduction Complex Assembly
Ibrahimi, O. A., Zhang, F., Lang Hrstka, S. C., Mohammadi, M., & Linhardt, R. J. (2004) · Biochemistry · doi:10.1021/bi0352320 · Cited by 193
Dougher, M., & Terman, B. I. (1999) · Oncogene · doi:10.1038/sj.onc.1202478 · Cited by 193
Roberts, D. M., Kearney, J. B., Johnson, J. H., Rosenberg, M. P., Kumar, R., & Bautch, V. L. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63711-x · Cited by 192
Matsumoto, T., Turesson, I., Book, M., Gerwins, P., & Claesson-Welsh, L. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200103096 · Cited by 187
Ashikari-Hada, S., Habuchi, H., Kariya, Y., & Kimata, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414581200 · Cited by 183 · cited 1×
“The early finding that binding of 125 I-VEGFA165 to VEGFR2 is enhanced by heparin (commonly used as a substitute for heparan sulphate (HS) in experimental model systems) has been confirmed by recent studies, which show that heparin amplifies signalling by VEGFA165, but not VEGFA121, through VEGFR2 (Ref”
ResultGille, H., Kowalski, J., Yu, L., Chen, H., Pisabarro, M. T., Davis-Smyth, T., & Ferrara, N. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.4064 · Cited by 181
p38 MAP Kinase—a molecular switch between VEGF‐induced angiogenesis and vascular hyperpermeability
Issbrücker, K., Martin, H. H., Hippenstiel, S., Springmann, G., Voswinckel, R., Gaumann, A., Breier, G., Drexler, H. C. A., Suttorp, N., & Clauss, M. (2003) · The FASEB Journal · doi:10.1096/fj.02-0329fje · Cited by 179
Contribution of marrow-derived progenitors to vascular and cardiac regeneration
Rafii, S., Meeus, S., Dias, S., Hattori, K., Heissig, B., Shmelkov, S. V., Rafii, D. C., & Lyden, D. C. (2002) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.2001.0285 · Cited by 173
West, D. C., Rees, C. G., Duchesne, L., Patey, S. J., Terry, C. J., Turnbull, J. E., Delehedde, M., Heegaard, C. W., Allain, F., Vanpouille, C., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410924200 · Cited by 173
Zeng, H., Sanyal, S., & Mukhopadhyay, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103130200 · Cited by 171
Dayanir, V., Meyer, R. D., Lashkari, K., & Rahimi, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009128200 · Cited by 170
Korpelainen, E., Karkkainen, M. J., Gunji, Y., Vikkula, M., & Alitalo, K. K. (1999) · Oncogene · doi:10.1038/sj.onc.1202288 · Cited by 165
Kearney, J. B., Ambler, C. A., Monaco, K.-A., Johnson, N., Rapoport, R. G., & Bautch, V. L. (2002) · Blood · doi:10.1182/blood.v99.7.2397 · Cited by 163
Christinger, H. W., Fuh, G., de Vos, A. M., & Wiesmann, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313237200 · Cited by 163
Activation of p38 Has Opposing Effects on the Proliferation and Migration of Endothelial Cells
McMullen, M. E., Bryant, P. W., Glembotski, C. C., Vincent, P. A., & Pumiglia, K. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407060200 · Cited by 160
Reynolds, A. R., Reynolds, L. E., Nagel, T. E., Lively, J. C., Robinson, S. D., Hicklin, D. J., Bodary, S. C., & Hodivala-Dilke, K. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2760 · Cited by 152
Boeuf, F. L., Houle, F., & Huot, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405493200 · Cited by 151
Endothelial gaps: time course of formation and closure in inflamed venules of rats
Baluk, P., Hirata, A., Thurston, G., Fujiwara, T., Neal, C. R., Michel, C. C., & McDonald, D. M. (1997) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1997.272.1.l155 · Cited by 142
Structure and Function of Placental Growth Factor
Falco, S. D., Gigante, B., & Persico, M. G. (2002) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00168-8 · Cited by 135
Guo, D.-Q., Wu, L.-W., Dunbar, J. D., Ozes, O. N., Mayo, L. D., Kessler, K. M., Gustin, J. A., Baerwald, M. R., Jaffe, E. A., Warren, R. S., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11216 · Cited by 133
Gallicchio, M., Mitola, S. M. F., Valdembri, D., Fantozzi, R., Varnum, B. C., Avanzi, G. C., & Bussolino, F. (2004) · Blood · doi:10.1182/blood-2004-04-1469 · Cited by 126
Crystal Structures of Novel Vascular Endothelial Growth Factors (VEGF) from Snake Venoms
Suto, K., Yamazaki, Y., Morita, T., & Mizuno, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411395200 · Cited by 121
Ito, N., Wernstedt, C., Engström, U., & Claesson-Welsh, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23410 · Cited by 113
Sakai, R., Henderson, J. T., O’Bryan, J. P., Elia, A., Saxton, T. M., & Pawson, T. J. (2000) · Neuron · doi:10.1016/s0896-6273(00)00156-2 · Cited by 109
Hiratsuka, S., Kataoka, Y., Nakao, K., Nakamura, K., Morikawa, S., Tanaka, S., Katsuki, M., Maru, Y., & Shibuya, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.355-363.2005 · Cited by 103
Hemangioblasts, angioblasts, and adult endothelial cell progenitors
Schatteman, G. C., & Awad, O. (2003) · The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology · doi:10.1002/ar.a.10131 · Cited by 99 · cited 1×
“In agreement with this notion, there is ample evidence that VEGFs are important for the regulation of haematopoietic cell development, survival, differentiation and migratio”
BackgroundVEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice
Kiba, A., Sagara, H., Hara, T., & Shibuya, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)03033-4 · Cited by 96
Wang, J., Zhang, X., & Groopman, J. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314015200 · Cited by 91
Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration
Doggrell, S. A. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.8.1421 · Cited by 90
Hiratsuka, S., Nakao, K., Nakamura, K., Katsuki, M., Maru, Y., & Shibuya, M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.346-354.2005 · Cited by 89
Zeng, H., Zhao, D., Yang, S., Datta, K., & Mukhopadhyay, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209712200 · Cited by 85
The Carboxyl Terminus of VEGFR-2 Is Required for PKC-mediated Down-Regulation
Singh, A. J., Meyer, R., Band, H., & Rahimi, N. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-08-0749 · Cited by 81 · cited 1×
“Internalization and degradation of VEGFR2 requires protein kinase C (PKC)-dependent phosphorylation of the receptor C-terminal tai”
BackgroundWARNER, A. J., Lopez‐Dee, J., KNIGHT, E. L., Feramisco, J. R., & Prigent, S. A. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3470501 · Cited by 80
Zebrafish and Xenopus tadpoles: Small animal models to study angiogenesis and lymphangiogenesis
Ny, A., Autiero, M., & Carmeliet, P. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.10.018 · Cited by 78
Hughes, D. C. (2001) · Journal of Molecular Evolution · doi:10.1007/s002390010195 · Cited by 75
Fournier, E., Dubreuil, P. C., Birnbaum, D., & Borg, J. (1995) · PubMed · Cited by 69
The bloody fate of endothelial stem cells: Figure 1.
Kubo, H., & Alitalo, K. K. (2003) · Genes & Development · doi:10.1101/gad.1071203 · Cited by 61 · cited 1×
“In agreement with this notion, there is ample evidence that VEGFs are important for the regulation of haematopoietic cell development, survival, differentiation and migratio”
BackgroundCheng, L., Jia, H., Löhr, M., Bagherzadeh, A., Holmes, D. I. R., Selwood, D., & Zachary, I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402488200 · Cited by 47
Vascular endothelial growth factor receptor 3 in hypoxia‐induced vascular development
Nilsson, I., Rolny, C., Wu, Y. L., Pytowski, B., Hicklin, D., Alitalo, K. K., Claesson, L., & M, S. W. ̈. (2004) · The FASEB Journal · doi:10.1096/fj.03-1276com · Cited by 42 · cited 1×
“VEGFR3 expression is upregulated in differentiating embryonic stem cells that are cultured in a hypoxic atmospher”
BackgroundSignal transduction by VEGF receptor-1 wild type and mutant proteins
Ito, N., Huang, K., & Claesson, L. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00209-1 · Cited by 39
Semaphorins: Green Light for Redox Signaling?
Ventura, A., & Pelicci, P. G. (2002) · Science Signaling · doi:10.1126/stke.2002.155.pe44 · Cited by 30
Cited by
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
VEGF in signaling and disease: beyond discovery and development
Apte, R. S., Chen, D. S., & Ferrara, N. (2019) · Cell · doi:10.1016/j.cell.2019.01.021 · Cited by 2,721
“NRP-2 performs a similar role in regulating lymphangiogenesis through its interactions with VEGFR3 (adapted from Ferrara and Adamis, 2016).”
BackgroundInfluentialDevelopment, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452
3D bioprinting of collagen to rebuild components of the human heart
Lee, A., Hudson, A. R., Shiwarski, D. J., Tashman, J. W., Hinton, T. J., Yerneni, S., Bliley, J. M., Campbell, P. G., & Feinberg, A. W. (2019) · Science · doi:10.1126/science.aav9051 · Cited by 1,782
Comprehensive review of targeted therapy for colorectal cancer
Xie, Y.-H., Chen, Y.-X., & Fang, J.-Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0116-z · Cited by 1,687
Metadata
- Authors
- Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L.
- Affiliations
- Uppsala University (SE)
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2006-05
- Volume
- 7
- Issue
- 5
- Pages
- 359-371
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2091774189
- Cited by
- 3,122
- References
- 141
- Citations by year
- 2026: 88 · 2025: 107 · 2024: 116 · 2023: 127 · 2022: 127 · 2021: 158 · 2020: 160 · 2019: 156 · 2018: 156 · 2017: 176 · 2016: 202 · 2015: 184 · 2014: 212 · 2013: 231 · 2012: 190
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
- Keywords
- VEGF receptors, VEGF signaling, VEGFR1, VEGFR2, VEGFR-3, angiogenesis, pathological angiogenesis, vascular development, endothelial cells, signal transduction, anti-angiogenic cancer therapy
- MeSH terms
- Animals, Humans, Stem Cells, Signal Transduction, Neovascularization, Physiologic, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factors, Embryonic Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.